Bridgehead Communications

SureScreen Diagnostics

Lateral-flow diagnostics manufacturer

Diagnostics & imaging

Derby-based, family-run manufacturer of lateral-flow and rapid diagnostic test kits, an NHS supplier since 2010 that produced 20 million UK-manufactured rapid COVID-19 tests for the UK government.

The read

SureScreen Diagnostics manufactures lateral-flow and rapid diagnostic test kits, including drug and alcohol tests, infectious-disease tests such as COVID-19, flu and Strep A, and health-screening products, supplying the NHS since 2010 and producing 20 million UK-manufactured rapid COVID-19 tests under a UK government contract.

A family-run business, it won two King's Awards for Enterprise in 2023, for Innovation and International Trade, reflecting both its UK manufacturing base and export reach into the EU, Australia, Central America and South East Asia.

The Bridgehead view

SureScreen's dual King's Awards in the same year, for innovation and export, is a rare double worth leading a story with, particularly for UK manufacturing and reshoring narratives around diagnostics supply.

FAQs

About this page

No. The MedTech Index is independent editorial coverage — we track and write up companies we judge genuinely significant in the sector, and inclusion is not for sale. Where shown, coverage of SureScreen Diagnostics above is drawn from public reporting, not sponsored content.

We map the sector by who is actually shaping it: funding, product reach, regulatory engagement and the coverage they earn. The MedTech Index is maintained by our editorial team and updated as the market moves, not compiled from vendor submissions.

Yes. If you represent SureScreen Diagnostics, or anything here looks out of date, get in touch through our contact page and we will review it.

Work with us

Building a medtech brand?

We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.

Working across the healthcare sector?

We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.

The firm that knows medtech

We map this sector because
we represent it.

Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.